{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:16:04Z","timestamp":1761178564719,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.canrad.2022.06.013","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T10:07:47Z","timestamp":1660903667000},"page":"766-770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pr\u00e9servation d\u2019organe dans les cancers du rectum\u00a0: quels arguments en faveur de la radioth\u00e9rapie\u00a0?"],"prefix":"10.1016","volume":"26","author":[{"given":"A.","family":"Larrouy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8627-4616","authenticated-orcid":false,"given":"V.","family":"Vendrely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2022.06.013_bib0160","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.sla.0000257358.56863.ce","article-title":"The TME Trial after a median follow-up of 6\u00a0years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma","volume":"246","author":"Peeters","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.canrad.2022.06.013_bib0165","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2022.06.013_bib0170","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1093\/annonc\/mdx351","article-title":"Late toxicities and clinical outcome at 5\u00a0years of the ACCORD 12\/0405-PRODIGE 02\u00a0trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer","volume":"28","author":"Azria","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2022.06.013_bib0175","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/SLA.0b013e3181dae4ed","article-title":"Postoperative complications following surgery for rectal cancer","volume":"251","author":"Paun","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.canrad.2022.06.013_bib0180","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/01.sla.0000171299.43954.ce","article-title":"Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer","volume":"242","author":"Hendren","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.canrad.2022.06.013_bib0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3\u00a0trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2022.06.013_bib0190","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3\u00a0trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2022.06.013_bib0195","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1470-2045(15)00004-2","article-title":"Effect of adding mFOLFOX6\u00a0after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2\u00a0trial","volume":"16","author":"Garcia-Aguilar","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2022.06.013_bib0200","doi-asserted-by":"crossref","first-page":"8688","DOI":"10.1200\/JCO.2005.02.1329","article-title":"Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer","volume":"23","author":"R\u00f6del","year":"2005","journal-title":"JCO"},{"key":"10.1016\/j.canrad.2022.06.013_bib0205","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fonc.2019.00318","article-title":"Organ preservation in rectal cancer: the patients\u2019 perspective","volume":"9","author":"Gani","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2022.06.013_bib0210","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(17)31056-5","article-title":"Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3\u00a0trial","volume":"390","author":"Rullier","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2022.06.013_bib0215","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.gassur.2006.09.005","article-title":"Patterns of failure and survival for nonoperative treatment of stage c0\u00a0distal rectal cancer following neoadjuvant chemoradiation therapy","volume":"10","author":"Habrgama","year":"2006","journal-title":"J Gastrointestinal Surg"},{"key":"10.1016\/j.canrad.2022.06.013_bib0220","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1200\/JCO.2011.37.7176","article-title":"Wait-and-See policy for clinical complete responders after chemoradiation for rectal cancer","volume":"29","author":"Maas","year":"2011","journal-title":"JCO"},{"key":"10.1016\/j.canrad.2022.06.013_bib0225","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","article-title":"Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study","volume":"391","author":"van der Valk","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2022.06.013_bib0230","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/annonc\/mdw062","article-title":"Long-course oxaliplatin-based preoperative chemoradiation versus 5\u00d75Gy and consolidation chemotherapy for cT4\u00a0or fixed cT3\u00a0rectal cancer: results of a randomized phase III study","volume":"27","author":"Bujko","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2022.06.013_bib0235","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1007\/s00330-013-2956-1","article-title":"Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy?","volume":"23","author":"Sassen","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1016\/j.canrad.2022.06.013_bib0240","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1470-2045(15)00120-5","article-title":"High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study","volume":"16","author":"Appelt","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2022.06.013_bib0245","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S1470-2045(15)00215-6","article-title":"Organ preservation for clinical T2N0\u00a0distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2\u00a0trial","volume":"16","author":"Garcia-Aguilar","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2022.06.013_bib0250","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S2468-1253(19)30410-8","article-title":"Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2\u00a0randomised trial","volume":"5","author":"Rullier","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.canrad.2022.06.013_bib0255","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.amjsurg.2020.01.001","article-title":"Predictors for complete pathological response for stage II and III rectal cancer following neoadjuvant therapy\u00a0\u2014\u00a0A systematic review and meta-analysis","volume":"220","author":"Huang","year":"2020","journal-title":"Am J Surg"},{"key":"10.1016\/j.canrad.2022.06.013_bib0260","doi-asserted-by":"crossref","first-page":"e45388","DOI":"10.1371\/journal.pone.0045388","article-title":"P53\u00a0status as a predictive biomarker for patients receiving neoadjuvant radiation-based treatment: a meta-analysis in rectal cancer","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canrad.2022.06.013_bib0265","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/SLA.0b013e31822b8cfa","article-title":"Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer","volume":"254","author":"Garcia-Aguilar","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.canrad.2022.06.013_bib0270","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1200\/JCO.2016.66.6826","article-title":"DNA Mismatch repair deficiency in rectal cancer: benchmarking its impact on prognosis, neoadjuvant response prediction, and clinical cancer genetics","volume":"34","author":"de Rosa","year":"2016","journal-title":"JCO"},{"key":"10.1016\/j.canrad.2022.06.013_bib0275","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jamcollsurg.2015.04.010","article-title":"Extended intervals after neoadjuvant therapy in locally advanced rectal cancer: the key to improved tumor response and potential organ preservation","volume":"221","author":"Probst","year":"2015","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.canrad.2022.06.013_bib0280","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1245\/s10434-015-4687-9","article-title":"Assessment of clinical complete response after chemoradiation for rectal cancer with digital rectal examination, endoscopy, and MRI: selection for organ-saving treatment","volume":"22","author":"Maas","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.canrad.2022.06.013_bib0285","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijrobp.2012.05.017","article-title":"Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy","volume":"85","author":"Appelt","year":"2013","journal-title":"Int J Radia Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.06.013_bib0290","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","article-title":"Operative versus nonoperative treatment for stage 0\u00a0distal rectal cancer following chemoradiation therapy: long-term results","volume":"240","author":"Habr-Gama","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.canrad.2022.06.013_bib0295","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3109\/0284186X.2014.975840","article-title":"Organ preservation in rectal adenocarcinoma (T1) T2-T3\u00a0Nx M0. Historical overview of the Lyon Sud\u2013Nice experience using contact X-ray brachytherapy and external beam radiotherapy for 120\u00a0patients","volume":"54","author":"Gerard","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2022.06.013_bib0300","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.ijrobp.2019.08.042","article-title":"Image guided adaptive endorectal brachytherapy in the nonoperative management of patients with rectal cancer","volume":"105","author":"Garant","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.06.013_bib0305","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.22.00032","article-title":"Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy","author":"Garcia-Aguilar","year":"2022","journal-title":"JCO"},{"key":"10.1016\/j.canrad.2022.06.013_bib0155","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1200\/JCO.2022.40.16_suppl.3512","article-title":"Contact x-ray brachytherapy (Papillon) in addition to chemoradiotherapy to improve organ preservation in early cT2-T3\u00a0rectal adenocarcinoma: the 3-year results of OPERA randomized trial (NCT02505750)","volume":"40","author":"Gerard","year":"2022","journal-title":"JCO"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321822001214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321822001214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:34:30Z","timestamp":1761136470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321822001214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":31,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1278321822001214"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2022.06.013","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pr\u00e9servation d\u2019organe dans les cancers du rectum\u00a0: quels arguments en faveur de la radioth\u00e9rapie\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2022.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}]}}